Last reviewed · How we verify

NCT06357923

Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age

Recruiting now NA Last updated 27 September 2024
What this trial tests

NA trial testing dosage in Aging in 100 participants. Currently enrolling.

Timeline
26 September 2024
Primary endpoint
26 September 2026
26 September 2026

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nice
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date26 September 2024
Primary completion26 September 2026
Estimated completion26 September 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

Adults 60 to 99, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects \> 60 years of age respecting a male/female ratio = 1.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06357923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing